According to Foresight News, Nasdaq-listed MEI Pharma has announced the launch of a $100 million Litecoin treasury strategy. This initiative marks a significant move by the company into the cryptocurrency space, reflecting a growing trend among corporations to diversify their financial strategies with digital assets.